PCSA
NASDAQ · Pharmaceuticals
Processa Pharmaceuticals Inc
$1.93
+0.09 (+4.89%)
Open$1.94
Previous Close$1.84
Day High$1.95
Day Low$1.86
52W High$9.00
52W Low$1.04
Volume—
Avg Volume32.2K
Market Cap5.27M
P/E Ratio—
EPS$-5.77
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,811.9% upside
Current
$1.93
$1.93
Target
$36.90
$36.90
$23.79
$36.90 avg
$41.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.71M | 2.46M | 2.10M |
| Net Income | 319.8K | 302.9K | 327.4K |
| Profit Margin | 11.8% | 12.3% | 15.6% |
| EBITDA | 521.3K | 563.7K | 431.6K |
| Free Cash Flow | 364.0K | 435.1K | 285.7K |
| Rev Growth | +2.4% | +0.4% | +18.3% |
| Debt/Equity | 0.28 | 0.35 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |